Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 11Other solid neoplasm 6Tumor-Agnostic 4CNS 4Thoracic 2Sarcoma 2Gynecologic 2Breast 2Head & Neck 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

pembrolizumab 46Paclitaxel 46Gemcitabine 41Carboplatin 37Docetaxel 35Bevacizumab 27Cisplatin 25Irinotecan 22Nivolumab 20Fluorouracil 20Erlotinib Hydrochloride 18Pemetrexed 17Capecitabine 17Sorafenib 16Magnetic Resonance Spectroscopy 16Cetuximab 16Afatinib 16Leucovorin 15regorafenib 14olaparib 13Specimen Handling 13Oxaliplatin 13trametinib 12Biopsy 12130-nm albumin-bound paclitaxel 11eribulin 10atezolizumab 10epothilone B 9Radiotherapy 9Midazolam 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × irinotecan sucrosofate × Tumor-Agnostic × Clear all
NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
681 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00062842 2020-03-04

Study of Irinotecan on a Weekly Schedule in Children

Baylor College of Medicine

Phase 1 Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT00364143 2019-07-05

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

Yakult Honsha Co., LTD

Phase 1 Completed
40 enrolled
Tumor-Agnostic

Neoplasms

NCT02640365 2017-01-31

DOUBLIRI

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1 Completed
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡